8-K

                                    FORM 8-K


                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549



                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported): January 27, 2003



                             MEDTOX SCIENTIFIC, INC.
             (Exact name of registrant as specified in its charter)


                                    Delaware
                 (State or other jurisdiction of incorporation)


 1-11394                                                            95-3863205
(Commission File Number)                       (IRS Employer Identification No.)


402 West County Road D
St. Paul, Minnesota                                                      55112
(Address of principal executive offices)                              (Zip Code)


                                 (651) 636-7466
              (Registrant's telephone number, including area code)









Item 9.           Regulation FD Disclosure

     On January  27,  2003,  the company  issued a press  release  regarding  an
industry article that was written  highlighting the company. A copy of the press
release is attached as Exhibit 99.1.






                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                               MEDTOX Scientific, Inc.




Date:  January 27, 2003                        By:       /s/ Richard J. Braun
                                                         -----------------------
                                               Name:     Richard J. Braun
                                               Title:    Chief Executive Officer

EX-99

                                                                    Exhibit 99.1
DATE: January 27, 2003

FROM:
MEDTOX Scientific, Inc.
402 West County Road D
St. Paul, MN  55112
Contact:  Stephen Anderson (877) 715-7236

FOR IMMEDIATE RELEASE

             MEDTOX SCIENTIFIC, INC., OVERVIEWED IN INDUSTRY REPORT

     St.  Paul,  Minn.,  January  27,  2003  - An  article  highlighting  MEDTOX
Scientific,  Inc. (Amex:  TOX) in The Dark Report on Tuesday,  December 9, 2002,
can be accessed on the Internet at http://www.medtox.com/MTXWeb/News/News.asp

MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high
quality specialized  laboratory and  on-site/point-of-collection  (POC) devices.
The company also supports  customers with complete  logistics,  data and program
management  services.  MEDTOX develops and manufactures  diagnostic  devices for
quick and  economical  on-site/point-of-collection  analysis for drugs of abuse,
therapeutic drugs and biological and agricultural toxins and provides employment
drug screening and occupational health testing.  MEDTOX is a leader in providing
esoteric  laboratory testing services to hospitals and laboratories  nationwide.
This  includes  both  central   laboratory   and   bio-analytical   testing  for
pharmaceutical  clinical  trials.  To be  automatically  alerted by e-mail about
company    information,    please   go   to    http://www.corporate-ir.net/ireye
/ir_site.zhtml?ticker=tox&script=1900 and follow the directions on the page. For
more information see http://www.medtox.com.

Note: The referenced article was not prepared by MEDTOX Scientific,  Inc. MEDTOX
is not responsible for its accuracy or completeness,  and the opinions expressed
in the article are those of its author.